Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (7): 776-778.DOI: 10.3969/j.issn.1673-8640.2021.07.023
Previous Articles Next Articles
Received:2020-05-10
Online:2021-07-30
Published:2021-07-26
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.07.023
| [1] |
SELUK L, TALIANSKY A, YONATH H, et al. A large screen for paraneoplastic neurological autoantibodies;diagnosis and predictive values[J]. Clin Immunol, 2019, 199:29-36.
DOI URL |
| [2] |
PETERSON K, ROSENBLUM M K, KOTANIDES H, et al. Paraneoplastic cerebellar degeneration. Ⅰ. A clinical analysis of 55 anti-Yo antibody-positive patients[J]. Neurology, 1992, 42(10):1931-1937.
DOI URL |
| [3] |
MCKEON A, TRACY J A, PITTOCK S J, et al. Purkinje cell cytoplasmic autoantibody type 1 accompaniments:the cerebellum and beyond[J]. Arch Neurol, 2011, 68(10):1282-1289.
DOI URL |
| [4] |
DARNELL R B, POSNER J B. Paraneoplastic syndromes involving the nervous system[J]. N Engl J Med, 2003, 349(16):1543-1554.
DOI URL |
| [5] |
GIOMETTO B, GRISOLD W, VITALIANI R, et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database:a European study from 20 centers[J]. Arch Neurol, 2010, 67(3):330-335.
DOI URL |
| [6] |
GRAUS F, DELATTRE J Y, ANTOINE J C, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes[J]. J Neurol Neurosurg Psychiatry, 2004, 75(8):1135-1140.
DOI URL |
| [7] |
VENKATRAMAN A, OPAL P. Paraneoplastic cerebellar degeneration with anti-Yo antibodies-a review[J]. Ann Clin Transl Neurol, 2016, 3(8):655-663.
DOI URL |
| [8] |
VEDELER C A, ANTOINE J C, GIOMETTO B, et al. Management of paraneoplastic neurological syndromes:report of an EFNS Task Force[J]. Eur J Neurol, 2006, 13(7):682-690.
DOI URL |
| [9] |
SADEGHIAN H, VERNINO S. Progress in the management of paraneoplastic neurological disorders[J]. Ther Adv Neurol Disord, 2010, 3(1):43-52.
DOI URL |
| [10] |
SUTTON I J, FURSDON DAVIS C, ESIRI M M, et al. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus[J]. Ann Neurol, 2001, 49(2):253-257.
DOI URL |
| [11] | HASADSRI L, LEE J, WANG B H, et al. Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung[J]. Case Rep Neurol Med, 2013, 2013:725936. |
| [12] |
AMYES E, CURNOW J, STARK Z, et al. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration[J]. J Neuroimmunol, 2001, 114(1-2):259-264.
DOI URL |
| [13] |
HIDA C, TSUKAMOTO T, AWANO H, et al. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration[J]. Arch Neurol, 1994, 51(6):555-558.
DOI URL |
| [14] |
JARIUS S, WILDEMANN B. 'Medusa head ataxia':the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3:anti-Yo/CDR2,anti-Nb/AP3B2,PCA-2,anti-Tr/DNER,other antibodies,diagnostic pitfalls,summary and outlook[J]. J Neuroinflammation, 2015, 12:168.
DOI URL |
| [15] |
ABOUL-ENEIN F, HÖFTBERGER R, BUXHOFER-AUSCH V, et al. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome[J]. Neuropathol Appl Neurobiol, 2008, 34(2):248-252.
DOI URL |
| [16] |
LITVAN I, BHATIA K P, BURN D J, et al. Movement Disorders Society Scientific Issues Committee report:SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders[J]. Mov Disord, 2003, 18(5):467-486.
DOI URL |
| [17] | JANKOVIC J. Progressive supranuclear palsy:paraneoplastic effect of bronchial carcinoma[J]. Neurology, 1985, 35(3):446-447. |
| [18] |
GOLBE L I, MILLER D C, DUVOISIN R C. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism[J]. Mov Disord, 1989, 4(2):147-152.
DOI URL |
| [19] |
TAN J H, GOH B C, TAMBYAH P A, et al. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma[J]. Parkinsonism Relat Disord, 2005, 11(3):187-191.
DOI URL |
| [20] |
MATSUMOTO L, YAMAMOTO T, HIGASHIHARA M, et al. Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes[J]. Mov Disord, 2007, 22(5):728-731.
DOI URL |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
